AGER and lung disorder: Collectively, these studies suggest that the AGE–RAGE axis not only contributes to the progression of fibrosis but that sRAGE functions as a crucial protective factor, potentially offering a therapeutic target to mitigate the advancement of fibrosis in lung diseases.